Сonditions and diseases


AIDS/HIV
ALS
Alzheimer's Disease
Anemia
Anti-Aging Treatment
Arterial Hypertension
Autism
Cancer
Diabetes Treatment
Eye Diseases
Idiopathic Encephalopathy
Ischemic Heart Disease
Liver Diseases
MD Treatment
Multiple Sclerosis Treatment
Parkinson Treatment
Rheumatoid Arthritis
SMA
Ulcerative Colitis. Crohn’s Disease
News about stem cells
Stem cell treatment protects bone marrow from damaging chemotherapy effects in cancer patients
12 May
Stem cell therapy can protect cancer patients from damaging side-effects of chemotherapy, a new trial in the US suggests.
New Approach to Treating Muscular Dystrophy With Stem Cells
05 May
Scientists from the Lillehei Heart Institute (University of Minnesota) have developed a new efficient process of making muscle cells from human stem cells and for the first time ever effectively treated with these cells muscular dystrophy in a mice model.
A New Brain Stem Cell Discovered
29 April
Adult brain contains stem cells, and Researchers at Lund University (Switzerland) found a new type of these cells.
All news

Immune substituting therapy with the use of fetal cell suspensions in cases of HIV infection (AIDS)


Smikodoub Alexander, Pilipchak Elena

Cell Therapy Clinic of National Medical University and Embryonic Tissues Center "EmCell"

Immune substituting therapy by means of transplantation of fetal cell suspensions having high contents of stem cells of hemopoiesis was carried out in 32 HIV infected patients, among which one man was a carrier, two patients (one man and one woman) suffered from AIDS-AC, and 29 patients (7 women and 22 men) suffered from AIDS. Average age of patients was 35 years (20 to 54). Transplantations were carried out by intravenous and subcutaneous administration of fetal cell suspensions. In addition, applications of fetal extracts were performed. All patients easily agreed to transplantations and endured them satisfactorily.

In 50% cases, syndrome of the early posttransplantation state improvement was observed on the 3rd to 5th day: appetite, sleep, general state and emotional tonus improved, weariness decreased.

Studies of the immune status were performed prior to the transplantation and after on the 7th, 12th, 30th and 60th days, and subsequently depending on a patient's state. Considerable and statistically valid improvement of CD3+, CD4+ and CD8+ indices was observed on the 12th day and remained during 2 months. The CD4+/CD8+ ratio increased during the first week; it however decreased later on.

In 20 patients, pathology of the nervous system was observed (astheno-neurotic syndrome, paresis of muscles in lower extremities, peripheral neuropathy). In this group, syndrome of the early posttransplantation state improvement was observed in 68% cases. Also observed were an increase in the amount of movements of affected extremities and gradual inmprovement in peripheral nerves functioning in the course of 2 months.

In 10 patients, pathology of the respiratory system was observed (bronchitis, pneumonia, pulmonary tuberculosis), accompanied by increase of the body temperature up to subfebrile level and higher. 2 weeks after transplantation, against the background of standard therapy, a decrease of the bronchoobstructive syndrome was observed in patients suffering from bronchitis and pneumonia. In patients suffering from tuberculosis, general state improved, and decrease in the body temperature was noted in some patients.

About fetal
stem cells
Contacts FAQs Congresses and Conferences